13.94

2.12% +0.29

After Hours: 13.94

Sabra Healthcare REIT Inc (SBRA)

Overview News Price History Option Chain Discussions Forecast Dividend History

Sabra Healthcare REIT Inc stock is currently priced at $13.94, with a 24-hour trading volume of 1.62M. It has seen a +2.12% increased in the last 24 hours and a -2.59% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $13.66 pivot point. If it approaches the $13.98 resistance level, significant changes may occur.

Previous Close:

$13.65

Open:

$13.71

24h Volume:

1.62M

Market Cap:

$3.23B

Revenue:

$647.51M

Net Income/Loss:

$13.76M

P/E Ratio:

-35.74

EPS:

-0.39

Net Cash Flow:

$300.57M

1W Performance:

+2.05%

1M Performance:

-2.59%

6M Performance:

+0.36%

1Y Performance:

+27.54%

1D Range:

$13.62

$14.07

52W Range:

$10.30

$14.91

Sabra Healthcare REIT Inc Stock (SBRA) Company Profile

Name

Sabra Healthcare REIT Inc

Sector

Real Estate (265)

Industry

REIT - Healthcare Facilities (3)

Phone

(888) 393-8248

Address

18500 Von Karman Avenue, Suite 550, Irvine, CA

Employee

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

SBRA's Discussions on Twitter

Sabra Healthcare REIT Inc Stock (SBRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-24	Initiated	Deutsche Bank	Buy
Oct-17-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Oct-16-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-10-23	Upgrade	BofA Securities	Neutral → Buy
Oct-03-23	Initiated	Wedbush	Outperform
Sep-20-23	Upgrade	Jefferies	Hold → Buy
Aug-11-23	Upgrade	BofA Securities	Underperform → Neutral
Jul-27-23	Initiated	Berenberg	Hold
Apr-20-23	Initiated	Wells Fargo	Underweight
Dec-13-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Nov-14-22	Downgrade	BofA Securities	Neutral → Underperform
Oct-10-22	Downgrade	Robert W. Baird	Outperform → Neutral
Jun-30-22	Downgrade	Jefferies	Buy → Hold
Jun-03-22	Initiated	CapitalOne	Equal Weight
May-25-22	Upgrade	Mizuho	Neutral → Buy
Apr-18-22	Downgrade	Barclays	Overweight → Equal Weight
Mar-11-22	Upgrade	BofA Securities	Underperform → Neutral
Feb-18-22	Initiated	KeyBanc Capital Markets	Sector Weight
Feb-01-22	Initiated	Credit Suisse	Neutral
Oct-08-21	Initiated	Robert W. Baird	Outperform
Sep-30-21	Upgrade	Truist	Hold → Buy
Jul-14-21	Resumed	Mizuho	Neutral
May-21-21	Upgrade	BMO Capital Markets	Market Perform → Outperform
May-10-21	Upgrade	Stifel	Hold → Buy
Jan-13-21	Upgrade	Jefferies	Hold → Buy
Jan-13-21	Downgrade	Mizuho	Buy → Neutral
Jan-08-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
Dec-03-20	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Sep-02-20	Resumed	Stifel	Hold
Jun-23-20	Upgrade	Scotiabank	Sector Underperform → Sector Perform
Jun-08-20	Resumed	JMP Securities	Mkt Perform
May-18-20	Upgrade	Berenberg	Hold → Buy
Mar-23-20	Downgrade	BofA/Merrill	Neutral → Underperform
Feb-26-20	Upgrade	Mizuho	Neutral → Buy
Feb-05-20	Initiated	Berenberg	Hold
Dec-20-19	Initiated	Mizuho	Neutral
Dec-18-19	Upgrade	Citigroup	Sell → Neutral
Oct-14-19	Resumed	BofA/Merrill	Neutral
Sep-23-19	Downgrade	Citigroup	Neutral → Sell
Sep-03-19	Initiated	Barclays	Overweight
Dec-18-18	Downgrade	SunTrust	Buy → Hold
Nov-16-18	Downgrade	BofA/Merrill	Neutral → Underperform
May-21-18	Upgrade	Raymond James	Mkt Perform → Outperform
Mar-26-18	Upgrade	BofA/Merrill	Underperform → Neutral
Feb-22-18	Reiterated	Stifel	Hold
Dec-21-17	Downgrade	Jefferies	Buy → Hold
Sep-25-17	Initiated	CapitalOne	Equal Weight

View All

Sabra Healthcare REIT Inc Stock (SBRA) Latest News

Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks Investment Research

National Health: Lots To Love, But Valuation Still On The High Side

Seeking Alpha

Alexander's (ALX) Lags Q4 FFO Estimates

Zacks Investment Research

Sabra Healthcare REIT Inc Stock (SBRA) Financials Data

Sabra Healthcare REIT Inc (SBRA) Revenue 2024

SBRA reported a revenue (TTM) of $647.51 million for the quarter ending December 31, 2023, a +3.63% rise year-over-year.

Sabra Healthcare REIT Inc (SBRA) Net Income 2024

SBRA net income (TTM) was $13.76 million for the quarter ending December 31, 2023, a +117.73% increase year-over-year.

Sabra Healthcare REIT Inc (SBRA) Cash Flow 2024

SBRA recorded a free cash flow (TTM) of $300.57 million for the quarter ending December 31, 2023, a -4.80% decrease year-over-year.

Sabra Healthcare REIT Inc (SBRA) Earnings per Share 2024

SBRA earnings per share (TTM) was $0.05 for the quarter ending December 31, 2023, a +114.71% growth year-over-year.

Sabra Healthcare REIT Inc Stock (SBRA) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Costa Michael Lourenco	Executive VP, CFO & Secretary	Sep 01 '23	Buy	12.63	1,947	24,591	183,218

As of September 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 350 Skilled Nursing/Transitional Care facilities, (ii) 91 Senior Housing communities (“Senior Housing - Leased”), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 11 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing - Managed communities. As of September 30, 2018, Sabra's real estate properties held for investment included 49,954 beds/units and its unconsolidated joint venture included 7,652 beds/units, spread across the United States and Canada.